| GERMANY | WP2 | |||
| Organization | NAPKON/SÜP | |||
| Name of cohort | CrossSctoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON) | |||
| Referring partner | University Hospital Frankfurt | |||
| Cohort Information | Country(-ies), cities, regions or centers involved | Germany | ||
| Time of data collection | 11/2020 | 12/2024 | ||
| Enrolment | Inactive | |||
| Study setting | Multi-centers | |||
| Population | Age | Children,Adolescents,Adults,Elderly | ||
| Type | Prospective | |||
| Total number of patients | 2753 | |||
| Site of enrolment (WP2) | Outpatient,Inpatient,ICU | |||
| Data collection | Clinical data | True | ||
| Serological data | True | |||
| Genetic data | True | |||
| Sample collection | True | |||
| Sample collected | Whole blood | Yes | ||
| PBMC | Yes | |||
| Dry-spot blood | No | |||
| Plasma | Yes | |||
| Serum | Yes | |||
| Stool | Yes | |||
| NP swabs | Yes | |||
| Other | Urine | |||
| Description | The cross-sectoral platform is part of the National Pandemic Cohort Network (NAPKON) and is used to provide a comprehensive and harmonized collection of data and biomaterial for researchers from national consortia, pharmaceutical companies and for participation in international research collaborations for the purpose of studying COVID-19 disease and future pandemics. | |||